TWD 77.8
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 130.66 Million TWD | -10.95% |
2022 | 146.73 Million TWD | 10.51% |
2021 | 132.77 Million TWD | 7.47% |
2020 | 123.54 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 24.92 Million TWD | -40.67% |
2024 Q1 | 42.01 Million TWD | 14.0% |
2023 Q4 | 36.85 Million TWD | 20.91% |
2023 FY | 130.66 Million TWD | -10.95% |
2023 Q3 | 30.48 Million TWD | -6.03% |
2023 Q2 | 32.43 Million TWD | 4.98% |
2023 Q1 | 30.89 Million TWD | -8.15% |
2022 FY | 146.73 Million TWD | 10.51% |
2022 Q4 | 33.63 Million TWD | 0.0% |
2021 FY | 132.77 Million TWD | 7.47% |
2020 FY | 123.54 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Bio Preventive Medicine Corp. | -73.28 Million TWD | 278.296% |
Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 177.746% |
Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 241.856% |
Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 160.072% |
NaviFUS Corp. | -65.72 Million TWD | 298.792% |
G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | -80.475% |
TaiRx, Inc. | -212.29 Million TWD | 161.549% |
Sinew Pharma Inc. | -170.92 Million TWD | 176.447% |
Lin BioScience, Inc. | -687.19 Million TWD | 119.014% |
TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 2260.807% |
Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 154.891% |
Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 352.335% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 47.945% |
AP Biosciences Inc | -339.29 Million TWD | 138.51% |
Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 79.117% |
RBC Bioscience Corporation | 6.43 Million TWD | -1932.1% |
Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 52.456% |
EirGenix Inc. | -915.2 Million TWD | 114.277% |
Enimmune corporation | -223.74 Million TWD | 158.399% |
Lukas Biomedical Inc. | -47.35 Million TWD | 375.936% |
BRIM Biotechnology, Inc. | -688.02 Million TWD | 118.991% |
3D Global Biotech Inc. | -57.95 Million TWD | 325.473% |
TaiMed Biologics Inc. | -194.81 Million TWD | 167.073% |
Mycenax Biotech Inc. | -682.84 Million TWD | 119.135% |
TCI GENE Inc. | 11.67 Million TWD | -1019.369% |
SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 442.303% |
Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 109.953% |
Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 353.161% |
Feng Chi Biotech Corp. | 22.79 Million TWD | -473.289% |
NeoCore Technology Co., Ltd. | -64.64 Million TWD | 302.125% |
TWi Biotechnology, Inc. | -170.68 Million TWD | 176.554% |
Neith Corporation | -40.03 Million TWD | 426.391% |
Sunny Pharmtech Inc. | -63.32 Million TWD | 306.355% |
VBI | -6.6 Million TWD | 2079.458% |
Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 75.776% |
GeneReach Biotechnology Corp. | -166.27 Million TWD | 178.585% |
Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 451.578% |
CHO Pharma, Inc. | -306.08 Million TWD | 142.689% |
Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 291.705% |
MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 202.443% |
Visgeneer Inc. | -19.58 Million TWD | 767.027% |
BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | -162.678% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 248.332% |
Sagittarius Life Science Corp | -55.03 Million TWD | 337.403% |
BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 183.585% |
GlycoNex Incorporation | -178.36 Million TWD | 173.258% |
Medigen Biotechnology Corp. | -561.29 Million TWD | 123.279% |
Pharmosa Biopharm Inc. | 8.45 Million TWD | -1445.222% |
PharmaEngine, Inc. | 274.65 Million TWD | 52.425% |
Intech Biopharm Corporation | -337.98 Million TWD | 138.659% |
Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 1323.217% |
BiOptic Inc. | 37.74 Million TWD | -246.157% |
TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 4.437% |
Senhwa Biosciences, Inc. | -296.3 Million TWD | 144.098% |
NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | -1191.146% |
OBI Pharma, Inc. | -1.04 Billion TWD | 112.486% |
Savior Lifetec Corporation | 30.03 Million TWD | -335.112% |
Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 312.324% |
Level Biotechnology Inc. | 62.9 Million TWD | -107.716% |
Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 111.266% |
Meribank Biotech Co., Ltd | -125.34 Million TWD | 204.243% |
Acepodia, Inc. | -817.31 Million TWD | 115.987% |
Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 126.75% |